On the first implementation day of the new National Reimbursement Drug List, Hansoh Pharma's Xinyue for the rare disease NMOSD was prescribed for the first time as a reimbursable drug across China
On March 1, 2023, the National Reimbursement Drug List for Basic Medical Insurance, Work-Related Injury Insurance and Maternity Insurance (2022) was o...
2023.03.01
